AzTrials
AzTrials

ProsthesesNCT05952765

Pink Esthetic Score Around Immediate Implants Using PDDM as Jumping Gap Filling Material.

A study testing Immediate implant in people with Prostheses and Endosseous Dental Implant Failure, run by Cairo University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Will there be a difference in Pink Esthetic score and soft tissue changes around immediate implants in maxillary esthetic zone following grafting the jumping gap with partially demineralized dentin matrix compared with xenograft? Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Prostheses, Endosseous Dental Implant Failure
What is being tested?
Immediate implant
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteEgypt
Study dates
Aug 2023to Jun 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients above 18 years of age; with non-restorable teeth requiring replacement with immediate implants in the maxillary esthetic zone.
  • Absence of active infection at the surgical site.
  • Adequate primary stability following immediate implant placement.
  • Intact socket walls following the extraction.
  • Class I dental socket based on a preoperative CBCT scan
  • Buccal plate thickness more than 1 mm and thick biotype.
  • Compliant patients who will sign an informed consent and agree to the follow up period.

Who cannot join

  • Poor oral hygiene or the lack of regular maintenance.
  • Individuals with compromised immune system or debilitating systemic disease.
  • The presence of parafunctional habits (bruxism or clenching).
  • External root resorption.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Oral and Dental Medicine- Cairo University

    Cairo, Cairo Governorate, 35855

    Manal Hosny Mostafa, Professor, (+202) 23642938, manal.hosny@dentistry.cu.edu.eg

    Mohamed Atef Bassiouny, lecturer, (+20)1224302609, Matef@hotmail.com

Other trials in Egypt

About this study

Official title: Evaluation of Pink Esthetic Score and Soft Tissue Changes Following Immediate Implants Using Partially Demineralized Dentin Matrix as Jumping Gap Filling Material Versus Xenograft. A Randomized Clinical Trial.

Will there be a difference in Pink Esthetic score and soft tissue changes around immediate implants in maxillary esthetic zone following grafting the jumping gap with partially demineralized dentin matrix compared with xenograft?

Read the detailed description

This study aims to evaluate the soft tissue changes as well as hard tissue changes around immediate implants in maxillary esthetic zone following grafting the jumping gap with partially demineralized dentin matrix in comparison to xenograft.

Because xenogeneic bone is so readily available in substantial quantities, it has been the subject of notable research. However, because they contain organic material from a foreign species, xenogeneic bones are inherently very antigenic.

According to experimental results, PDDM encourages bone regeneration in a manner like autogenous bone. Both cortical bone and autogenous tooth grafts share similar physical and chemical characteristics, including optimal biodegradability, not requiring a separate surgery to harvest the graft and space maintenance capabilities. PDDM is a valuable comparator to autogenous bone in ARP and around dental implants in guided bone regeneration procedures

Being tested
Immediate implant
Keywords
alveolar bone, immediate implant, soft tissue changes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Immediate implantProcedure or surgery

    • Local anesthesia Septanest special® will be administered prior to the procedure.
    • Teeth extraction will be initiated by intrasulcular incision via 15 C blade without flap elevation.
    • The tooth to be extracted will be luxated atraumatically using periotomes and thin straight elevator and delivered using forceps.
    • The socket will be inspected for integrity, using a UNC graduated periodontal probe. grafting material either experimental or control will be used to graft jumping gap.
Study groups in NCT05952765
Study groupRoleWhat they receive
Partially demineralized dentin matrix graftExperimental* A high-speed fine finishing stone and saline irrigation will be used to clean extracted teeth from periodontal ligaments, soft tissue attachments, caries, and restorations if present. * Teeth particles will be partially demineralized using nitric acid 2% for fifteen minutes. * Finally, the prepared partially demineralized dentin matrix graft granules will be washed twice with distilled water and phosphate buffered saline * Immediate implant of appropriate dimensions will be placed and the previously prepared partially demineralized dentin matrix graft will be used to graft the jumping gap. * Customized healing abutment will be used. * In Osseo integrated implants temporary abutment will be removed and impressions for final restoration will be performed after 3 months.
Receives: Procedure: Immediate implant
xenograftActive comparator* After tooth extraction, thorough curettage will be performed. * Immediate implant of appropriate dimensions will be placed, and the jumping gap will be grafted with xenograft "Cerabone" . * Customized healing abutment will be used. * In Osseo integrated implants temporary abutment will be removed and impressions for final restoration will be performed after 3 months.
Receives: Procedure: Immediate implant

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pink esthetic score

    a fourteen point scale to evaluate pink esthetics. The pink esthetic score (PES) estimates the esthetic results of soft tissue surrounding the implant with regarding 7 points : mesial, distal papilla, soft tissue margin, soft tissue contour, alveolar process, colour, texture. the score of zero will be lowest and two will be the highest for each of the seven points with zero being the lowest and 14 being the highest.

    Measured: twelve months after final restoration

Secondary outcomes (3)
  1. Vertical and horizontal radiographic changes in bone dimensions

    cone beam CT will be used to detect vertical and horizontal changes

    Measured: immediate post operative and twelve months after final restoration

  2. Midfacial mucosal alteration

    rubber base impressions taken before the surgical procedure and 12 months after implant restoration. Then, casts were poured with type IV die stone and optically scanned. The obtained models were compared by digital superimposition in a matching software to measure the vertical alterations of the buccal peri-implant soft tissue.

    Measured: preoperative and twelve months after final restoration

  3. Patient satisfaction

    a twelve point questionnaire to evaluate patient satisfaction

    Measured: one year after final restoration

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jul 2023
  2. Study startAug 2023 (estimated)
  3. Primary completionFeb 2025 (estimated)
  4. Study completionJun 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
24 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05952765
Sponsor's protocol ID
7691
Status last verified
Jul 2023
First submitted
8 Jul 2023
Last updated
19 Jul 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: baseline data and follow up measurements will be shared while keeping patients' identity protected.

Questions about this trial

What is this clinical trial studying?

A study testing Immediate implant in people with Prostheses and Endosseous Dental Implant Failure, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mihad Ibrahim, M.Sc ((+20)1008551124, mihad.ibrahim@dentistry.cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pink esthetic score (time frame: twelve months after final restoration). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jul 2023; AzTrials last refreshed its copy on 29 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in